A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects
Completed
Galecto Biotech AB
Phase 1
This was a Phase 1, randomized, double-blind, placebo-controlled, first-in-human study in
which the safety, tolerability, and pharmacokinetics of orally administered GB1211 will be
evaluated in healthy adult subjects and adult subjects with indication of suspected
Nonalcoholic steatohepatitis (NASH) and liver fibrosis.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Withdrawn
Covance
Phase 1/Phase 2
This study is a randomised, double-blind, placebo controlled, phase Ib trial in subjects with
suspected or confirmed non-alcoholic steatohepatitis (NASH) and liver fibrosis
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Withdrawn
Galecto Biotech AB
Phase 1/Phase 2
This study is a randomised, double-blind, placebo controlled, phase Ib trial in subjects with
suspected or confirmed non-alcoholic steatohepatitis (NASH) and liver fibrosis
A Single and Repeat Dose Trial in Participants With Hepatic Impairment
Recruiting
Comac Medical
Phase 1/Phase 2
This study is a a single (open-label) and repeat dose (randomised, placebo controlled) trial
to assess the safety, tolerability and pharmacokinetics of GB1211 (Gal-3 inhibitor) in
participants with hepatic impairment (Child Pugh B and Child Pugh C)
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
